Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DASH vs MRNA✓SelectedUSD · MRNADASH vs MRNA performance historyLatest closeAs of-2.87%11/17
Stock and ETF performance explorer

DASH vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-28.1%
MRNA return
-11.9%
Excess return
-16.2%
Maximum drawdown
-81.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.9%-3.9%+1.1%-2.5%
7D-7.5%-17.6%+10.1%-5.7%
30D-12.8%-5.1%-7.7%-12.5%
3M-22.5%+220.8%-243.3%-37.5%
6M+3.6%+321.7%-318.1%-23.0%
YTD-27.2%+601.3%-628.4%-53.6%
1Y-21.7%+735.2%-756.9%-52.6%
3Y+73.2%+170.5%-97.4%+21.0%
5Y-28.1%-14.6%-13.5%-35.0%
All-28.1%-11.9%-16.2%-35.0%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling